3

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: July 2, 2019
Period of Report: June 30, 2019
Accession Number: 0001144204-19-033653

View Document ↗ View on SEC.gov ↗